IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones . : Verified by Johnson & Johnson , 2 sept 09 . Fase III Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy ( TRS ) .

04 septiembre 2009

Verified by Johnson & Johnson , 2 sept 09 . Fase III Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy ( TRS ) .

A Study of the Safety and Effectiveness of Trabetedin Versus Doxorubicin-based Chemotherapy in Patients With Translocation-Related Sarcomas (TRS).

...